DHT Blockers Stop Hair Loss by Cutting Scalp DHT
How do DHT blockers work to stop hair loss?
Pattern hair loss isn't your follicles giving up, it's a hormone signal cutting every growth cycle short before the hair can finish the job. DHT blockers don't feed the follicle or wake it up, they turn that signal down so the follicle gets its full run again. That's why the result feels slow and why it only holds while you keep taking it.
- Conversion: An enzyme called 5-alpha reductase turns testosterone into dihydrotestosterone.
- Docking: That hormone binds the androgen receptor two to five times more tightly than testosterone.
- Miniaturization: In genetically sensitive follicles the growth phase shortens and each new hair returns finer.
- Interruption: A blocker either cuts how much hormone is made or occupies the receptor so the message never lands.
- Recovery: Living follicles stretch their growth phase again, which shows as density at around twelve months.
Oral enzyme inhibitors cut scalp dihydrotestosterone by roughly sixty percent and serum levels by around seventy percent, and stopping treatment reverses the accumulated benefit within about twelve months.
What is DHT and how does the body produce it from testosterone?
Only a small slice of your testosterone ever becomes dihydrotestosterone, and yet that slice does most of the androgen talking. It's about tenfold better at switching the receptor on, so the signal it delivers is wildly out of proportion to how much of it you're carrying. Where the enzyme that makes it lives matters as much as how much gets made.
| Criteria | Type 1 enzyme | Type 2 enzyme |
|---|---|---|
| Main sites | Sebaceous glands, skin, liver | Prostate, genital skin, scalp dermal papilla |
| Role in hair loss | Background supply | Direct driver at the follicle |
| Under a selective inhibitor | Still running | Shut down |
| Under a dual inhibitor | Shut down | Shut down |
5-alpha reductase converts testosterone into dihydrotestosterone, which binds the androgen receptor with roughly two to five times the affinity of testosterone and around tenfold the potency at switching it on.
Why does DHT shrink hair follicles in people who are genetically susceptible?
Two people can have identical hormone panels and completely different hairlines, because the difference isn't in the hormone at all, it's in how loudly the receptor answers. Your androgen receptor gene sets that volume, which is why bloodwork almost never explains what you're seeing in the mirror. The fringe at the back is spared for the same reason those follicles keep growing after they're moved onto a bald crown.
- Binding: Dihydrotestosterone docks with a sensitive receptor in the dermal papilla at the base of the hair.
- Signal switch: The papilla raises transforming growth factor beta, which ends the growth phase early.
- Shrinkage: Each cycle restarts with a smaller papilla, and papilla volume sets shaft diameter.
- Degradation: Thick pigmented hair steps down toward short, wispy, barely pigmented vellus hair.
- Closure: Once the opening scars over, no drop in hormone brings that follicle back.
Susceptibility lives in the androgen receptor rather than in hormone levels, and a mix of hair calibres within one small area under magnification is the diagnostic signature that separates pattern loss from an even diffuse shed.
What is the difference between blocking the enzyme that makes DHT and blocking the receptor it binds to?
Think of it as cutting the power at the breaker instead of unplugging one appliance. An enzyme inhibitor stops the hormone being made, while a receptor blocker leaves it circulating and just blocks the socket it plugs into. Which one you're offered depends less on the pathway than on who you are.
| Criteria | Enzyme inhibitor | Receptor blocker |
|---|---|---|
| Point of action | Upstream, before conversion | Downstream, at the follicle |
| Hormone levels | Lowered in blood and scalp | Left unchanged |
| Usual patient | Established route for men | Used far more in women |
| Trial evidence | Large randomised trials | Narrower for scalp hair |
| Side effect spread | Narrow sexual and mood cluster | Wider, needs closer monitoring |
Enzyme inhibition is the established route for male pattern loss because it carries the large randomised trial evidence, while receptor blockade is used far more in women, where the feminising effects that rule it out for men are not an obstacle.
How far do DHT levels have to fall before hair loss actually slows?
There's no magic number to hit, and chasing one is a good way to spend side effects for nothing. The trial data shows the first chunk of suppression does nearly all the work, and every percentage point after that buys less than the one before it. Past that point what limits you isn't hormone pressure, it's how much living follicle you still have.
Scalp tissue concentration matters more than the serum figure because the follicle only reacts to what reaches it locally, and since neither is measured outside research, response is judged on standardised photographs and hair counts.
What happens to the hair growth cycle once DHT levels drop?
Nothing new gets built here. You're not growing fresh follicles, you're handing the ones you already have their calendar back. That one distinction explains both the early shed that scares people off treatment and the fact that the back of your head doesn't change at all.
- Growth phase: Two to eight years normally, trimmed shorter on every androgen driven pass.
- Transition: About two weeks as the follicle winds down.
- Rest: Two to three months before the old hair is released.
- Reset: Lower the signal and dormant follicles restart, ejecting old hairs as a temporary shed.
- Rebuild: A longer growth phase builds a thicker shaft at roughly a centimetre a month.
Reduced shedding shows up first and genuine density gain arrives much later, so fixed angle photographs under identical lighting are the only reliable way to tell those two apart.
How long does it take before a DHT blocker produces a visible change?
Most people who quit walk away at exactly the point the treatment starts acting. The first three months hand you nothing but a possible shed, and the fair verdict doesn't land until a year in. Take your baseline photos before the first dose, because memory is a hopeless instrument for change this slow and holding your ground is a result you can't see without a comparison image.
Twelve months is the conventional assessment point, and published studies at that mark show the large majority of treated men holding their ground with roughly half showing visible improvement.
Do DHT blockers applied to the scalp work differently from those taken by mouth?
The route changes your exposure, not the target. A topical agent still shuts down the same enzyme at the same dermal papilla, and the pitch is that it does so with less of the drug reaching the rest of you. The evidence backs that partly, and the part it doesn't back is the part people bank on.
| Criteria | Topical | Oral |
|---|---|---|
| Scalp reduction | Comparable to an oral dose | Roughly sixty percent |
| Serum reduction | Smaller, but clearly not absent | Around seventy percent |
| Evidence base | Weaker and less studied | Large randomised trials |
| Pregnancy precautions | Apply in full | Apply in full |
| Consistency | Depends on vehicle, concentration, particle size | Standardised dose |
A topical route lowers systemic side effect risk rather than eliminating it, because a molecule small enough to cross the skin barrier also finds its way into the circulation.
What happens elsewhere in the body when DHT is suppressed?
This isn't a scalp drug that happens to carry side effects, it's a whole body hormone intervention you're taking for your hair. Most reported effects settle when people stop, but one of them can quietly distort a test result years down the line and one of them is absolute. Go in knowing where those lines sit and who's watching them with you.
- Sexual effects: Reduced libido and erectile difficulty at roughly one to two percent in trials.
- Mood: Depressive symptoms described, now carried in product labelling in several countries.
- PSA readings: Fall by about a third at the hair loss dose, hiding real problems.
- Pregnancy: Absolute contraindication, and broken or crushed tablets shouldn't be handled at all.
Prostate specific antigen readings fall by roughly a third at the hair loss dose and by about half at the prostate dose, so any PSA result taken during treatment has to be interpreted with that correction.
Why does hair loss resume when a DHT blocker is stopped?
These agents suppress a signal, they don't touch the sensitivity underneath it, so the enzyme is only inhibited while the drug is actually in you. With a short acting agent your hormone levels climb back close to baseline within about two weeks of the final dose. You land at the density you'd have had if you'd never started, which makes this a long horizon commitment rather than a course of treatment.
A short acting agent lets hormone levels return close to baseline within about two weeks of the last dose, and the accumulated hair benefit is reversed within roughly twelve months.
Do plant derived DHT blockers act on the same pathway as prescription ones?
The claim isn't fabricated. Saw palmetto and a handful of other botanicals genuinely do inhibit the enzyme in laboratory work, which is why the marketing has something to stand on. The argument gets settled on potency, and there it isn't close.
| Criteria | Plant extracts | Prescription inhibitors |
|---|---|---|
| Enzyme binding | Weak competitive inhibition | Nanomolar affinity |
| Suppression delivered | Not shown at doses you'd take | Sixty to over ninety percent |
| Trial evidence | Small, short, unreplicated | Large randomised trials |
| Batch consistency | Varies between products and runs | Held to pharmaceutical standard |
Plant derived blockers are plausible as a mild adjunct and unrealistic as a replacement, and a rinse off shampoo in contact with the scalp for sixty seconds has essentially no opportunity to deliver anything to a follicle.
